Abstract
We sought to estimate the risk of death and recurrent myocardial infarction associated with the use of calcium antagonists after myocardial infarction in a population-based cohort study. Calcium antagonists are commonly prescribed after myocardial infarction, but their long-term effects are not well established. Patients 25 to 69 years old with a suspected myocardial infarction were identified and followed up through a community-based register of myocardial infarction and cardiac death (part of the World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease [MONICA] Project in Newcastle, Australia). Data were collected by review of medical records, in-hospital interview and review of death certificates. From 1989 to 1993, 3,982 patients with a nonfatal suspected myocardial infarction were enrolled in the study. At hospital discharge, 1,001 patients were treated with beta-adrenergic blocking agents, 923 with calcium antagonists, 711 with both beta-blockers and calcium antagonists and 1,346 with neither drug. Compared with patients given beta-blockers, patients given calcium antagonists were more likely to suffer myocardial infarction or cardiac death (adjusted relative risk [RR] 1.4, 95% confidence int...Continue Reading
References
Jul 23, 1992·The New England Journal of Medicine·G A LamasE Braunwald
Jan 12, 1991·BMJ : British Medical Journal·M Eccles, C Bradshaw
Dec 1, 1991·Circulation·D Waters
Sep 1, 1991·Family Practice·C P Bradley
Jun 1, 1991·The American Journal of Cardiology·S YusufC Furberg
Oct 1, 1990·The American Journal of Cardiology
Nov 11, 1989·BMJ : British Medical Journal·P H HeldC D Furberg
Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
Jun 1, 1985·Circulation·W E BodenR S Shulman
Nov 1, 1986·British Heart Journal
Aug 18, 1988·The New England Journal of Medicine·UNKNOWN Multicenter Diltiazem Postinfarction Trial Research Group
Nov 8, 1986·British Medical Journal·R G WilcoxH G Mather
Mar 1, 1988·The American Journal of Cardiology·M A HlatkyD B Pryor
Aug 14, 1986·The New England Journal of Medicine·R S GibsonR E Kleiger
Feb 8, 1969·Lancet·R M NorrisA J Lee
Dec 1, 1983·American Heart Journal·C J PepineE Scott
Apr 1, 1984·Circulation·J E MullerD H Serfas
Sep 1, 1981·The American Journal of Cardiology·B SubramanianE B Raftery
Feb 18, 1982·The American Journal of Cardiology·K F HossackT A Ports
Aug 23, 1995·JAMA : the Journal of the American Medical Association·B M PsatyP W Wahl
Aug 23, 1995·JAMA : the Journal of the American Medical Association·J E BuringC H Hennekens
Sep 1, 1995·Circulation·L H Opie, F H Messerli
Sep 1, 1995·Circulation·R A Kloner
Sep 1, 1995·Circulation·C D FurbergJ V Meyer
Jun 1, 1994·Journal of Clinical Epidemiology·P M OdellW B Kannel
Jul 1, 1994·Circulation·H Tunstall-PedoeA Pajak
Oct 1, 1993·Stroke; a Journal of Cerebral Circulation·D TanneS Behar
Apr 20, 1996·Lancet·M PahorR Havlik
Jun 1, 1996·Circulation·H Tunstall-PedoeG Watt
Aug 24, 1996·Lancet·M PahorR J Havlik
Oct 10, 1996·The New England Journal of Medicine·M PackerD L DeMets
Jan 1, 1997·Journal of Clinical Epidemiology·V SalomaaK Kuulasmaa
Mar 1, 1997·Lancet·M H AldermanS Madhavan
Citations
Nov 11, 1998·Journal of the American College of Cardiology·C J PepineP Zellig
Mar 7, 2002·Annals of Epidemiology·Adrian R LevyMichal Abrahamowicz
Jun 10, 2000·Journal of Clinical Pharmacy and Therapeutics·K S McNamaraW T Friesen
Oct 3, 2015·The International Journal of Biochemistry & Cell Biology·Charumathi PushparajCarles Cantí
Oct 3, 2000·Progress in Cardiovascular Diseases·L H OpieW Kübler
May 26, 1999·Current Problems in Cardiology·M FreherM Gheorgiade
Dec 12, 2003·Angiology·Masami NishinoRita F Redberg
Mar 8, 2002·British Journal of Anaesthesia·M ZauggD R Spahn
Sep 28, 2001·British Journal of Anaesthesia·J W SearP Foex
May 17, 2006·Journal of Cardiovascular Pharmacology and Therapeutics·Naranjan S DhallaRamesh K Goyal
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·J R Kizer, S E Kimmel
Apr 30, 2003·Journal of Cardiovascular Pharmacology·Philip B AdamsonPeter J Schwartz
May 10, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Sandip ChaugaiHisatomi Arima